H.R.1266

Combating Illicit Xylazine Act aims to regulate xylazine by adding it to Schedule III of the Controlled Substances Act.

The Combating Illicit Xylazine Act seeks to address the misuse of xylazine by adding it to Schedule III of the Controlled Substances Act. This bill defines xylazine and its derivatives, prohibits its use except under specific conditions, and mandates reports to Congress on its prevalence and impacts. It also requires the United States Sentencing Commission to review and amend sentencing guidelines for offenses involving xylazine.